![](https://s3.amazonaws.com/brrmediauk-brrmedia-assets/company/logo/c29b9c3e78e36cea673926e5d9693d13.jpg)
Suda Limited Company Update
SUD Tue, 09 Jun 2015, 11:00am AEST
SUDA Ltd (ASX: SUD) is a drug delivery company utilising its proprietary OroMist® oro-mucosal drug delivery technology to develop low-risk, innovative pharmaceuticals that improve the health and lifestyle of patients. The many potential benefits of administering drugs through the oral mucosa, which is the moist lining of the oral cavity (ie: cheeks, tongue, gums and palate), include ease of use, lower dosage, reduced side effects and faster response time.
![](https://s3.amazonaws.com/brrmediauk-brrmedia-assets/company_contact/logo/f6783999-1481-4d83-8810-1bd34244684c.jpg)
Stephen Carter, CEO
CEO
Stephen Carter, CEO, CEO
Fri, 16 Oct 2015, 1:00pm AEDT
Stephen Carter, CEO, CEO
Wed, 26 Aug 2015, 11:05am AEST
Stephen Carter, CEO, CEO
Tue, 9 Jun 2015, 11:00am AEST